According to Syndax Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.43. In 2022 the company made an earnings per share (EPS) of -$2.45 a decrease over its 2021 EPS that were of $0.43.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.43 | -0.82% |
2022 | -$2.45 | -669.77% |
2021 | $0.43 | -122.87% |
2020 | -$1.88 | 1.62% |
2019 | -$1.85 | -36.43% |
2018 | -$2.91 | 0.69% |
2017 | -$2.89 | -39.16% |
2016 | -$4.75 | -67.94% |
2015 | -$14.82 | 334.66% |
2014 | -$3.41 | -62.86% |
2013 | -$9.18 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -10.29% | ๐บ๐ธ USA |